Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0001493152-25-006356
Filing Date
2025-02-13
Accepted
2025-02-13 13:38:10
Documents
1

Document Format Files

Seq Description Document Type Size
1 primary_doc.html SCHEDULE 13G/A  
1 primary_doc.xml SCHEDULE 13G/A 9864
  Complete submission text file 0001493152-25-006356.txt   11616
Mailing Address 55 POST RD WEST 2ND FLOOR WESTPORT CT 06880
Business Address 55 POST RD WEST 2ND FLOOR WESTPORT CT 06880 646-793-9056
Ayrton Capital LLC (Filed by) CIK: 0001698148 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SCHEDULE 13G/A

Mailing Address 360 MADISON AVENUE 25TH FLOOR NEW YORK NY 10017
Business Address 360 MADISON AVENUE 25TH FLOOR NEW YORK NY 10017 212 949 4319
Lucid Diagnostics Inc. (Subject) CIK: 0001799011 (see all company filings)

EIN.: 825488042 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SCHEDULE 13G/A | Act: 34 | File No.: 005-92965 | Film No.: 25619008
SIC: 3841 Surgical & Medical Instruments & Apparatus
(CF Office: 08 Industrial Applications and Services)